Reimagining Antibody
Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and will
Location: Germany, Bavaria, Munich
Employees: 11-50
Total raised: $227.24M
Founded date: 2016
Investors 4
| Date | Name | Website |
| - | OCCIDENT | occident.g... |
| - | Coparion | coparion.v... |
| - | Andera Par... | anderapart... |
| 17.07.2021 | High-Tech ... | htgf.de |
Funding Rounds 4
| Date | Series | Amount | Investors |
| 14.03.2024 | - | $139.9M | - |
| 04.05.2022 | Series B | $63.18M | Andera Par... |
| 24.09.2020 | Series A | $12.56M | - |
| 21.07.2020 | Series A | $11.6M | - |
Mentions in press and media 20
| Date | Title | Description | Source |
| 17.03.2024 | Tubulis Secures €128M Series B2 Funding for Cancer Treatment... | Tubulis, a Munich-based biotech startup, has successfully closed an upsized €128 million Series B2 f... | parsers.vc... |
| 14.03.2024 | Andera Partners’ portfolio company Tubulis closes upsized €1... | Andera Partners’ portfolio company Tubulis today announced the successful completion of an upsized a... | anderapart... |
| 14.03.2024 | Tubulis Closes Upsized €128M Series B2 Funding | Tubulis, a Munich, Germany-based oncology company, closed an upsized €128m ($138.8m) Series B2 finan... | finsmes.co... |
| 14.03.2024 | German biotech Tubulis rides wave of ADC interest to $138M f... | The antibody-drug conjugate (ADC) craze shows no signs of slowing down any time soon, judging by Tub... | fiercebiot... |
| 14.03.2024 | m4 Award winner Tubulis on the road to success: 128 million ... | The Munich Biotech-Startup and m4 Award winner Tubulis, located in Planegg/Martinsried closes an ups... | bio-m.org/... |
| 04.05.2022 | Super rich individuals are private equity’s growing LP base... | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 04.05.2022 | Tubulis picks up €60M Series B | Munich-based biotech startup Tubulis has raised €60 million in a round led by Andera Partners. The s... | pitchbook.... |
| 03.05.2022 | Tubulis Closes €60 Million Series B Financing to Accelerate ... | May 3, 2022 | htgf.de/en... |
| 03.05.2022 | Tackling toxicity, Tubulis lands $63M to advance ADC pipelin... | Antibody-drug conjugates (ADCs) have come a long way in recent years. Tubulis wants to advance the m... | fiercebiot... |
| 03.05.2022 | Andera Partners supports Tubulis in a €60 million Series B f... | Andera Partners, a leading European private equity player, through its biotech and medtech practice ... | anderapart... |
Show more